Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
An overview of potential yields from stablecoins, including yield farming, interest accounts, and risk considerations to optimize income.
27,570 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Space investors are watching SpaceX's stock swing as it moves from early enthusiasm to a more tempered pullback. This...
Rumors say PayPal might be acquired. Here’s how I’m evaluating the scenario, the potential outcomes, and the concrete...
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
Can Lumen Technologies stock your journey toward wealth? This article breaks down the company’s shift toward AI infra...
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
A SpaceX IPO could unlock funding for a bold, space-based data center vision. This deep dive explains what data cente...
Long-term investors chase multibagger dreams. This article explores a high-potential biotech setup with 26 late-stage...
Two rising names—Oklo and Centrus Energy—are shaping the future of U.S. nuclear energy. This guide breaks down which ...
Could a bold thesis around Oklo Inc. unlock life-changing gains? This forward-looking guide breaks down why nuclear e...
Could buying Joby Aviation stock set you up for life? This guide breaks down the opportunity, risks, and a practical ...
Investors are weighing the latest earnings from D-Wave Quantum. While losses persisted, revenue beat expectations in ...